abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Long-Term Investments
$561.04M
Quarterly · Period ending: · USD
HQL Long-Term Investments
Latest reported$561.04Mperiod ending
Latest reported$561.04Mperiod ending
HQL Quarterly Long-Term Investments ($123.50M → $561.04M)
Quarterly long-term investments
High-resolution chart · PNG
HQL long-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Investments (USD) |
|---|---|
| 561,042,427 | |
| 505,702,990 | |
| 392,759,034 | |
| 460,301,419 | |
| 429,949,675 | |
| 397,529,082 | |
| 432,642,096 | |
| 414,076,080 | |
| 444,985,467 | |
| 534,007,691 | |
| 503,197,893 | |
| 483,973,050 | |
| 397,205,019 | |
| 381,471,060 | |
| 420,077,261 | |
| 466,452,180 | |
| 436,901,937 | |
| 436,874,000 | |
| 382,208,000 | |
| 370,841,000 | |
| 337,723,000 | |
| 443,832,000 | |
| 462,235,000 | |
| 440,086,000 | |
| 295,541,000 | |
| 295,346,000 | |
| 229,776,000 | |
| 216,344,529 | |
| 170,000,000 | |
| 212,700,000 | |
| 255,400,000 | |
| 255,650,000 | |
| 255,900,000 | |
| 266,900,000 | |
| 277,900,000 | |
| 293,350,000 | |
| 308,800,000 | |
| 289,100,000 | |
| 269,400,000 | |
| 248,550,000 | |
| 227,700,000 | |
| 209,750,000 | |
| 191,800,000 | |
| 191,750,000 | |
| 191,700,000 | |
| 174,250,000 | |
| 156,800,000 | |
| 185,400,000 | |
| 214,000,000 | |
| 101,300,000 | |
| 132,100,000 | |
| 127,800,000 | |
| 123,500,000 |